Artwork

内容由peopleofpathology提供。所有播客内容(包括剧集、图形和播客描述)均由 peopleofpathology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Episode 183: Joseph Mossel - Revolutionizing Pathology with AI: A Conversation with IBEX Co-Founder

30:15
 
分享
 

Manage episode 422792301 series 3385006
内容由peopleofpathology提供。所有播客内容(包括剧集、图形和播客描述)均由 peopleofpathology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Jospeh Mossel co-founded Ibex in 2016. Since its inception, Ibex has remained committed to developing AI applications for clinical diagnostics.

The company achieved its first milestone in 2018 by deploying its first algorithm for prostate cancer. This algorithm not only enhanced diagnostic efficiency but also detected a diagnostic error, demonstrating the value of AI in pathology.

Over the years, IBEX has expanded its offerings to include algorithms for breast and gastric cancers, facing challenges due to the unique characteristics of each tissue type. However, through partnerships with healthcare organizations and pharmaceutical companies, IBEX has continued to innovate and grow.

This conversation covers the history of Ibex and some of their milestones. We conclude with a look toward the future of AI in pathology.

Links for this episode:

Health Podcast Network

LabVine Learning

Dress A Med scrubs

Digital Pathology Club

Ibex Medical Analytics

An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study

People of Pathology Podcast:

Twitter

Instagram

  continue reading

190集单集

Artwork
icon分享
 
Manage episode 422792301 series 3385006
内容由peopleofpathology提供。所有播客内容(包括剧集、图形和播客描述)均由 peopleofpathology 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Jospeh Mossel co-founded Ibex in 2016. Since its inception, Ibex has remained committed to developing AI applications for clinical diagnostics.

The company achieved its first milestone in 2018 by deploying its first algorithm for prostate cancer. This algorithm not only enhanced diagnostic efficiency but also detected a diagnostic error, demonstrating the value of AI in pathology.

Over the years, IBEX has expanded its offerings to include algorithms for breast and gastric cancers, facing challenges due to the unique characteristics of each tissue type. However, through partnerships with healthcare organizations and pharmaceutical companies, IBEX has continued to innovate and grow.

This conversation covers the history of Ibex and some of their milestones. We conclude with a look toward the future of AI in pathology.

Links for this episode:

Health Podcast Network

LabVine Learning

Dress A Med scrubs

Digital Pathology Club

Ibex Medical Analytics

An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study

People of Pathology Podcast:

Twitter

Instagram

  continue reading

190集单集

Όλα τα επεισόδια

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南